JENBURKT PHARMACEUTICALS
|
The Current P/S Ratio of JENBURKT PHARMACEUTICALS is 2.61.
Share Price | ₹820.5 | May 07,2024 |
Market Cap | ₹361.0 Cr | |
Sales-TTM | ₹138.3 Cr | TTM-Standalone Results |
Price/Sales | 2.61x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of JENBURKT PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹361.0 Cr] as on May 07,2024
(/) Sales [ ₹138.3 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 2.61x ]
Thus, for JENBURKT PHARMACEUTICALS , the investors are currently willing to pay '2.61 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of JENBURKT PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of JENBURKT PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of JENBURKT PHARMACEUTICALS
PS Ratio Performance Analysis for JENBURKT PHARMACEUTICALS
- JENBURKT PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 1.81x.
- JENBURKT PHARMACEUTICALS 's operated at median p/e ratio of 1.89x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, JENBURKT PHARMACEUTICALS 's p/e ratio peaked in Mar2023 at 2.15x.
- JENBURKT PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 1.23x.
How does JENBURKT PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
JENBURKT PHARMACEUTICALS | 138.3 | 2.61 | 361.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 47,444.6 | 7.66 | 363,535.0 |
CIPLA LTD | 25,350.2 | 4.42 | 112,058.0 |
DR REDDYS LABORATORIES LTD | 28,011.1 | 3.73 | 104,414.0 |
ZYDUS LIFESCIENCES LTD | 19,024.2 | 5.19 | 98,676.3 |
DIVIS LABORATORIES LTD | 7,492.8 | 13.86 | 103,845.0 |
MANKIND PHARMA LTD | 9,946.3 | 8.93 | 88,830.5 |
TORRENT PHARMACEUTICALS LTD | 10,474.0 | 8.46 | 88,586.4 |
LUPIN LTD | 20,010.8 | 3.67 | 73,400.8 |
AUROBINDO PHARMA LTD | 27,894.7 | 2.36 | 65,903.5 |
ABBOTT INDIA LTD | 5,753.4 | 9.50 | 54,645.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs JENBURKT PHARMACEUTICALS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.36x |
Max industry PS | 13.86x |
Median industry PS | 5.19x |
Average industry PS | 6.40x |
You may also like the below Video Courses